Table 8.
Intake estimates of Mn resulting from the use of the NF as an ingredient in the intended food categories or as food supplement at the maximum proposed use levels
| Population group | Age (years) | Mean Mn intake (mg/day) | P95th Mn intake (mg/day) | ||
|---|---|---|---|---|---|
| Lowesta | Highesta | Lowestb | Highestb | ||
| Infants | < 1 | 0.0040 | 0.0206 | 0.0013 | 0.0440 |
| Young childrenc | 1–< 3 | 0.0043 | 0.3261 | 0.0106 | 0.2462 |
| Other children | 3–< 10 | 0.0025 | 0.2869 | 0.0132 | 0.8577 |
| Adolescents | 10–< 18 | 0.0023 | 0.2649 | 0.0109 | 0.7233 |
| Adultsd | ≥ 18 | 0.0082 | 0.3358 | 0.0248 | 0.8887 |
| From food supplements only for adults | 2.5 | ||||
NF: novel food.
a
FAIM tool exposure estimate was generated on 7/7/2021. The lowest and the highest averages observed among all EU surveys are reported in these columns.
b
FAIM tool exposure estimate was generated on 7/7/2021. The lowest and the highest P95th observed among all EU surveys are reported in these columns (P95th based on less than 60 individuals are not considered).
c
Referred as ‘toddlers’ in the EFSA food consumption comprehensive database (EFSA, 2011).
d
Including elderly, very elderly, pregnant and lactating women.